top of page


Gelomics is an Australian company founded in 2018. Our mission is to provide the research community with the highest quality 3D cell culture technology at affordable prices. Our products are manufactured to industrial standards using validated protocols and enable reproducible studies with outstanding predictive value.

Dr Christoph Meinert.jpg

Dr Christoph Meinert

Managing Director

Dr Christoph Meinert completed his PhD in Bioengineering from the Queensland University of Technology in 2017. In addition to his expertise in hydrogel cultures that span many different cell types, Christoph has led the development of key technologies that enable 3D cell culture. 

Dr Peter Levett.JPG

Dr Peter Levett


Dr Peter Levett completed his joint PhD from Queensland University of Technology and University Medical Centre Utrecht in 2016. His work on photocrosslinkable hydrogels has been influential in the tissue engineering field.


Associate Professor

Travis Klein


A/Prof Travis Klein earned his PhD in bioengineering from the University of California, San Diego (UCSD) in 2005. His hydrogel experience goes back to the early days of his PhD, with alginate, and he has continued working with a range of hydrogels since then with his students and post-doctoral researchers. 


Distinguished Professor

Dietmar W. Hutmacher


D/Prof Dietmar W. Hutmacher is a biomedical engineer, educator, inventor, and creator of new intellectual property and entrepreneurial opportunities. He is a global leader in biomaterial science, biomedical and tissue engineering and regenerative medicine. D/Prof Hutmacher is one of few academics who translated a tissue engineering concept from bench to bedside.

IMG_6135 (1).jpeg

Jordan Davern 

Production Manager

Image from iOS.jpg

Hayley Zhang

Marketing Manager


Pawel Mieszczanek

Mechatronics Engineer

Portait Aaron.jpg

Aaron Foster

Mechatronics Engineer


Ross Kent


bottom of page